How a glass shortage could slow coronavirus vaccine development and distribution

There's more than science standing between a coronavirus vaccine and the American people.

The U.S. Heath and Human Services Department has moved to accelerate COVID-19 vaccine development, albeit separately from the rest of the world's efforts. But its eventual distribution will be hampered by an unprepared supply chain that has never had to deal with crisis of this scale before, Politico reports.

The U.S. is embarking on "Project Warp Speed" to produce a vaccine, rejecting a collaboration with the World Health Organization that could've let the U.S. access research from around the world. Taking shortcuts to speed up development is problematic in its own right, with the U.S. government giving developers permission to skip certain animal and human trials and perhaps eventually allowing the vaccine's emergency use before it's fully reviewed, Politico notes.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

After development comes the process of packaging and distributing the vaccine — and a whole host of other problems. Vaccines are packaged inside specialized glass vials, and the industry that produces that medical glass has been facing a sand shortage since before COVID-19 hit, Politico reports. Dr. Rick Bright, who was leading coronavirus vaccine development until his alleged ouster, says in his whistleblower complaint he warned of a shortage of borosilicate tubing that's needed to make vials, but his concerns were ignored.

The industries making stoppers and needles needed to contain vaccines are also ripe for shortages. Read more about the vaccine's looming supply chain problem at Politico.

Explore More

Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.